{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:20:09Z","timestamp":1790191209024,"version":"4.1.0"},"reference-count":104,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.bbmt.2015.07.003","type":"journal-article","created":{"date-parts":[[2015,7,11]],"date-time":"2015-07-11T12:31:59Z","timestamp":1436617919000},"page":"1707-1713","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["Systematic Nutritional Support in Allogeneic Hematopoietic Stem Cell Transplant Recipients"],"prefix":"10.1016","volume":"21","author":[{"given":"Shigeo","family":"Fuji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Einsele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bipin N.","family":"Savani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Kapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2015.07.003_bib1","first-page":"417","article-title":"A\u00a0multi-center international survey related to the nutritional support after hematopoietic stem cell transplantation endorsed by the ASIA Pacific Blood and Marrow Transplantation (APBMT)","volume":"03","author":"Fuji","year":"2012","journal-title":"Food Nutr Sci"},{"key":"10.1016\/j.bbmt.2015.07.003_bib2","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1177\/0884533612457179","article-title":"Medical nutrition therapy provided to adult hematopoietic stem cell transplantation patients","volume":"27","author":"Habschmidt","year":"2012","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.bbmt.2015.07.003_bib3","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.07.003_bib4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0140-6736(10)62037-5","article-title":"National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants","volume":"377","author":"Finucane","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2015.07.003_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(11)60679-X","article-title":"National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants","volume":"378","author":"Danaei","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2015.07.003_bib6","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nrendo.2011.183","article-title":"The worldwide epidemiology of type 2 diabetes mellitus\u2013present and future perspectives","volume":"8","author":"Chen","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.bbmt.2015.07.003_bib7","doi-asserted-by":"crossref","first-page":"g4596","DOI":"10.1136\/bmj.g4596","article-title":"Non-alcoholic fatty liver disease","volume":"349","author":"Sattar","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.bbmt.2015.07.003_bib8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/bmt.2013.128","article-title":"Impact of being overweight on outcomes of hematopoietic SCT: a meta-analysis","volume":"49","author":"Nakao","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib9","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/bmt.2012.201","article-title":"Trimming the fat: obesity and hematopoietic cell transplantation","volume":"48","author":"Weiss","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib10","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/bmt.2014.178","article-title":"Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT","volume":"49","author":"Fuji","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/bmt.2008.431","article-title":"Intensive glucose control after allogeneic hematopoietic stem cell transplantation: a retrospective matched-cohort study","volume":"44","author":"Fuji","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib12","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.bbmt.2010.04.009","article-title":"Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults","volume":"16","author":"Navarro","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib13","first-page":"1044","article-title":"A\u00a0low body mass index is correlated with poor survival after allogeneic stem cell transplantation","volume":"88","author":"Le Blanc","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2015.07.003_bib14","first-page":"461","article-title":"Impact of patient weight on non-relapse mortality after marrow transplantation","volume":"15","author":"Deeg","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00277-012-1573-4","article-title":"Body mass index and bioelectrical impedance phase angle as potentially modifiable nutritional markers are independent risk factors for outcome in allogeneic hematopoietic cell transplantation","volume":"92","author":"Urbain","year":"2013","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2015.07.003_bib16","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1182\/blood-2013-03-490334","article-title":"Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation","volume":"123","author":"Aplenc","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.07.003_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/TP.0b013e3182869d2f","article-title":"Obesity and its impact on transplantation and alloimmunity","volume":"96","author":"Heinbokel","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2015.07.003_bib18","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1056\/NEJMoa1008234","article-title":"Weight loss, exercise, or both and physical function in obese older adults","volume":"364","author":"Villareal","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2015.07.003_bib19","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/pbc.24272","article-title":"Malnutrition and obesity in pediatric oncology patients: causes, consequences, and interventions","volume":"59","author":"Co-Reyes","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2015.07.003_bib20","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/bmt.2014.315","article-title":"Pre-transplant diabetes mellitus is a risk factor for non-relapse mortality, especially infection-related mortality, after allogeneic hematopoietic SCT","volume":"50","author":"Takano","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3109\/07435800.2014.914037","article-title":"Impact of preexisting diabetes mellitus on transplantation outcomes in hematopoietic stem cell transplantation","volume":"40","author":"Radfar","year":"2015","journal-title":"Endocr Res"},{"key":"10.1016\/j.bbmt.2015.07.003_bib22","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.bbmt.2015.03.018","article-title":"Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study","volume":"21","author":"Sun","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib23","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/S0140-6736(09)60553-5","article-title":"Stress hyperglycaemia","volume":"373","author":"Dungan","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2015.07.003_bib24","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1056\/NEJMcp060094","article-title":"Clinical practice. Management of hyperglycemia in the hospital setting","volume":"355","author":"Inzucchi","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2015.07.003_bib25","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/S0140-6736(14)60613-9","article-title":"Prevention and management of type 2 diabetes: dietary components and nutritional strategies","volume":"383","author":"Ley","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2015.07.003_bib26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bbmt.2010.06.010","article-title":"Pretransplantation C-Peptide level predicts early posttransplantation diabetes mellitus and has an impact on survival after allogeneic stem cell transplantation","volume":"17","author":"Griffith","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib27","first-page":"3599","volume":"92","author":"Carreras","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.07.003_bib28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2015.07.003_bib29","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.bbmt.2011.04.009","article-title":"Pretransplantation liver function impacts on the outcome of allogeneic hematopoietic stem cell transplantation: a study of 455 patients","volume":"17","author":"Barba","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib30","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/bmt.2012.25","article-title":"Incidence, characteristics and risk factors of marked hyperbilirubinemia after allogeneic hematopoietic cell transplantation with reduced-intensity conditioning","volume":"47","author":"Barba","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib31","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/0884533614547084","article-title":"Gastrointestinal side effects and adequacy of enteral intake in hematopoietic stem cell transplant patients","volume":"30","author":"Walrath","year":"2015","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.bbmt.2015.07.003_bib32","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.nut.2008.02.021","article-title":"Nutritional recommendations in hematopoietic stem cell transplantation","volume":"24","author":"Martin-Salces","year":"2008","journal-title":"Nutrition"},{"key":"10.1016\/j.bbmt.2015.07.003_bib33","series-title":"Nutrition support of the hematopoietic cell transplant recipient. Thomas' Hematopoietic Cell Transplantation","first-page":"1551","author":"Lenssen","year":"2009"},{"key":"10.1016\/j.bbmt.2015.07.003_bib34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.clnu.2009.04.024","article-title":"ESPEN guidelines on parenteral nutrition: intensive care","volume":"28","author":"Singer","year":"2009","journal-title":"Clin Nutr"},{"key":"10.1016\/j.bbmt.2015.07.003_bib35","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0899-9007(02)00828-6","article-title":"Intensive monitoring program for oral food intake in patients undergoing allogeneic hematopoietic cell transplantation: a cost-benefit analysis","volume":"18","author":"Calvo","year":"2002","journal-title":"Nutrition"},{"key":"10.1016\/j.bbmt.2015.07.003_bib36","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/sj.bmt.1701747","article-title":"Parenteral nutrition following intensive cytotoxic therapy: an exploratory study on the need for parenteral nutrition after various treatment approaches for haematological malignancies","volume":"23","author":"Iestra","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ajh.21307","article-title":"Positive impact of maintaining minimal caloric intake above 1.0 x basal energy expenditure on the nutritional status of patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"84","author":"Fuji","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2015.07.003_bib38","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/bmt.2014.228","article-title":"Severe weight loss in 3 months after allogeneic hematopoietic SCT was associated with an increased risk of subsequent non-relapse mortality","volume":"50","author":"Fuji","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib39","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/0148607106030004345","article-title":"The incidence and impact of dextrose dose on hyperglycemia from parenteral nutrition (PN) exposure in hematopoietic stem cell transplant (HSCT) recipients","volume":"30","author":"Sheean","year":"2006","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.bbmt.2015.07.003_bib40","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/ajcn\/67.5.927","article-title":"Intravenous lipid dose and incidence of bacteremia and fungemia in patients undergoing bone marrow transplantation","volume":"67","author":"Lenssen","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.bbmt.2015.07.003_bib41","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/TP.0b013e3182558f60","article-title":"Better outcome of patients undergoing enteral tube feeding after myeloablative conditioning for\u00a0allogeneic stem cell transplantation","volume":"94","author":"Seguy","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2015.07.003_bib42","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/01.tp.0000229419.73428.ff","article-title":"Enteral feeding and early outcomes of patients undergoing allogeneic stem cell transplantation following myeloablative conditioning","volume":"82","author":"Seguy","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2015.07.003_bib43","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/bmt.2011.248","article-title":"Enteral nutrition: a first option for nutritional support of children following allo-SCT?","volume":"47","author":"Azarnoush","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib44","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.bmt.1705493","article-title":"Poor oral nutrition after allogeneic stem cell transplantation correlates significantly with severe graft-versus-host disease","volume":"38","author":"Mattsson","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib45","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.clnu.2013.07.012","article-title":"Enteral versus parenteral nutritional support in allogeneic haematopoietic stem-cell transplantation","volume":"33","author":"Guieze","year":"2014","journal-title":"Clin Nutr"},{"key":"10.1016\/j.bbmt.2015.07.003_bib46","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/sj.bmt.1702855","article-title":"Intensive enteral nutrition support in paediatric bone marrow transplantation","volume":"27","author":"Langdana","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib47","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/pbc.24275","article-title":"Enteral nutrition is feasible in pediatric stem cell transplantation patients","volume":"59","author":"Bicakli","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2015.07.003_bib48","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13063-015-0663-8","article-title":"Could enteral nutrition improve the outcome of patients with haematological malignancies undergoing allogeneic haematopoietic stem cell transplantation? A study protocol for a randomized controlled trial (the NEPHA study)","volume":"16","author":"Lemal","year":"2015","journal-title":"Trials"},{"key":"10.1016\/j.bbmt.2015.07.003_bib49","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.bbmt.2008.12.488","article-title":"The contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipients","volume":"15","author":"Hammer","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib50","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/01.tp.0000296482.50994.1c","article-title":"Hyperglycemia during the neutropenic period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation","volume":"84","author":"Fuji","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2015.07.003_bib51","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.2337\/dc08-0574","article-title":"Antecedent hyperglycemia is associated with an increased risk of neutropenic infections during bone marrow transplantation","volume":"31","author":"Derr","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbmt.2015.07.003_bib52","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10753-012-9533-7","article-title":"Severe hyperglycemia immediately after allogeneic hematopoietic stem-cell transplantation is predictive of acute graft-versus-host disease","volume":"36","author":"Gebremedhin","year":"2013","journal-title":"Inflammation"},{"key":"10.1016\/j.bbmt.2015.07.003_bib53","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.bbmt.2006.01.010","article-title":"Adverse clinical consequences of hyperglycemia from total parenteral nutrition exposure during hematopoietic stem cell transplantation","volume":"12","author":"Sheean","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib54","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbmt.2010.07.005","article-title":"Dysglycemia following glucocorticoid therapy for acute graft-versus-host disease adversely affects transplantation outcomes","volume":"17","author":"Pidala","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib55","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1378\/chest.09-1737","article-title":"Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis","volume":"137","author":"Marik","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.bbmt.2015.07.003_bib56","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bpa.2009.08.006","article-title":"Clinical benefits of tight glycaemic control: focus on the intensive care unit","volume":"23","author":"Mesotten","year":"2009","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"10.1016\/j.bbmt.2015.07.003_bib57","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa052521","article-title":"Intensive insulin therapy in the medical ICU","volume":"354","author":"Van den Berghe","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2015.07.003_bib58","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","article-title":"Intensive insulin therapy in critically ill patients","volume":"345","author":"van den Berghe","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2015.07.003_bib59","first-page":"S14","article-title":"Standards of medical care in diabetes\u20132014","volume":"37 Suppl 1","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbmt.2015.07.003_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP15672.GLSUPPL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015","volume":"21","author":"Handelsman","year":"2015","journal-title":"Endocr Pract"},{"key":"10.1016\/j.bbmt.2015.07.003_bib61","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/0148607111415628","article-title":"An insulin protocol for management of hyperglycemia in patients receiving parenteral nutrition is superior to ad hoc management","volume":"36","author":"Jakoby","year":"2012","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.bbmt.2015.07.003_bib62","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1177\/01486071040280S601","article-title":"Safe practices for parenteral nutrition","volume":"28","author":"Mirtallo","year":"2004","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.bbmt.2015.07.003_bib63","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11892-012-0335-y","article-title":"Management of hyperglycemia during enteral and parenteral nutrition therapy","volume":"13","author":"Gosmanov","year":"2013","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.bbmt.2015.07.003_bib64","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/jama.2008.943","article-title":"Sliding scale insulin\u2013time to stop sliding","volume":"301","author":"Hirsch","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.bbmt.2015.07.003_bib65","first-page":"1130","article-title":"Glycemic control in hospitalized patients not in intensive care: beyond sliding-scale insulin","volume":"81","author":"Nau","year":"2010","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.bbmt.2015.07.003_bib66","doi-asserted-by":"crossref","first-page":"S541","DOI":"10.1097\/01.CCM.0000278064.32780.D3","article-title":"Glutamine: mode of action in critical illness","volume":"35","author":"Wischmeyer","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bbmt.2015.07.003_bib67","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/CCM.0b013e31820eb774","article-title":"The effect of L-alanyl-L-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients","volume":"39","author":"Grau","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bbmt.2015.07.003_bib68","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.clnu.2014.05.006","article-title":"The influence of parenteral glutamine supplementation on glucose homeostasis in critically ill polytrauma patients-A randomized-controlled clinical study","volume":"34","author":"Grintescu","year":"2015","journal-title":"Clin Nutr"},{"key":"10.1016\/j.bbmt.2015.07.003_bib69","doi-asserted-by":"crossref","first-page":"821","DOI":"10.7326\/0003-4819-116-10-821","article-title":"Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study","volume":"116","author":"Ziegler","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2015.07.003_bib70","first-page":"790","article-title":"A\u00a0randomised, double-blinded, placebo-controlled, pilot study of parenteral glutamine for allogeneic stem cell transplant patients","volume":"13","author":"Blijlevens","year":"2005","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.bbmt.2015.07.003_bib71","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/014860710002400261","article-title":"Effect of oral glutamine supplementation during bone marrow transplantation","volume":"24","author":"Coghlin Dickson","year":"2000","journal-title":"JPEN J\u00a0Parenter Enteral Nutr"},{"key":"10.1016\/j.bbmt.2015.07.003_bib72","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/bmt.2008.27","article-title":"Efficacy of glutamine-supplemented parenteral nutrition on short-term survival following allo-SCT: a randomized study","volume":"41","author":"da Gama Torres","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib73","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/0148607199023003117","article-title":"Oral and parenteral glutamine in bone marrow transplantation: a randomized, double-blind study","volume":"23","author":"Schloerb","year":"1999","journal-title":"JPEN J\u00a0Parenter Enteral Nutr"},{"key":"10.1016\/j.bbmt.2015.07.003_bib74","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1097\/TP.0b013e31821ab959","article-title":"Glutamine-enriched nutrition does not reduce mucosal morbidity or complications after stem-cell transplantation for childhood malignancies: a prospective randomized study","volume":"91","author":"Uderzo","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2015.07.003_bib75","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.clnu.2009.04.011","article-title":"ESPEN Guidelines on Parenteral Nutrition: non-surgical oncology","volume":"28","author":"Bozzetti","year":"2009","journal-title":"Clin Nutr"},{"key":"10.1016\/j.bbmt.2015.07.003_bib76","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/bmt.2009.41","article-title":"Systematic review and meta-analyses of studies of glutamine supplementation in haematopoietic stem cell transplantation","volume":"44","author":"Crowther","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib77","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1212722","article-title":"A\u00a0randomized trial of glutamine and antioxidants in critically ill patients","volume":"368","author":"Heyland","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2015.07.003_bib78","doi-asserted-by":"crossref","first-page":"d1542","DOI":"10.1136\/bmj.d1542","article-title":"Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients","volume":"342","author":"Andrews","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.bbmt.2015.07.003_bib79","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0148607114529994","article-title":"Glutamine and antioxidants in the critically ill patient: a post hoc analysis of a large-scale randomized trial","volume":"39","author":"Heyland","year":"2015","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.bbmt.2015.07.003_bib80","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/07315724.2002.10719248","article-title":"Omega-3 fatty acids in inflammation and autoimmune diseases","volume":"21","author":"Simopoulos","year":"2002","journal-title":"J\u00a0Am Coll Nutr"},{"key":"10.1016\/j.bbmt.2015.07.003_bib81","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/sj.bmt.1703226","article-title":"Oral eicosapentaenoic acid for complications of bone marrow transplantation","volume":"28","author":"Takatsuka","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib82","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/0884533612462900","article-title":"Review and clinical update on parenteral nutrition-associated liver disease","volume":"28","author":"Tillman","year":"2013","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.bbmt.2015.07.003_bib83","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1592\/phco.27.5.715","article-title":"Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia","volume":"27","author":"McKenney","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bbmt.2015.07.003_bib84","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.bbmt.2013.12.554","article-title":"Serial profile of vitamins and trace elements during the acute phase of allogeneic stem cell transplantation","volume":"20","author":"Nannya","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib85","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/bmt.2012.124","article-title":"Nutritional support in patients with GVHD of the digestive tract: state of the art","volume":"48","author":"van der Meij","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib86","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.bbmt.2015.02.016","article-title":"Emerging influence of the intestinal microbiota during allogeneic hematopoietic cell transplantation: control the gut and the body will follow","volume":"21","author":"Docampo","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib87","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/sj.bmt.1705268","article-title":"Weight loss and reduced body mass index: a critical issue in children with multiorgan chronic graft-versus-host disease","volume":"37","author":"Browning","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib88","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.bmt.1703352","article-title":"Weight loss and malnutrition in patients with chronic graft-versus-host disease","volume":"29","author":"Jacobsohn","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib89","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1200\/JCO.2011.40.0457","article-title":"Longitudinal changes in body mass and composition in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem-cell transplantation","volume":"30","author":"Inaba","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2015.07.003_bib90","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0002-8223(21)01637-0","article-title":"Prevalence of nutrition-related problems among long-term survivors of allogeneic marrow transplantation","volume":"90","author":"Lenssen","year":"1990","journal-title":"J\u00a0Am Diet Assoc"},{"key":"10.1016\/j.bbmt.2015.07.003_bib91","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/bmt.2014.145","article-title":"Malnutrition in patients with chronic GVHD","volume":"49","author":"Bassim","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib92","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0261-5614(98)80316-6","article-title":"Energy expenditure during allogeneic and autologous bone marrow transplantation","volume":"17","author":"Chamouard Cogoluenhes","year":"1998","journal-title":"Clin Nutr"},{"key":"10.1016\/j.bbmt.2015.07.003_bib93","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/bmt.2012.158","article-title":"Longitudinal follow-up of nutritional status and its influencing factors in adults undergoing allogeneic hematopoietic cell transplantation","volume":"48","author":"Urbain","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib94","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.coph.2015.04.003","article-title":"Cachexia and sarcopenia: mechanisms and potential targets for intervention","volume":"22","author":"Argiles","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.bbmt.2015.07.003_bib95","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/leu.2011.254","article-title":"Clinical laboratory markers of\u00a0inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity","volume":"26","author":"Grkovic","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2015.07.003_bib96","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/SPC.0000000000000016","article-title":"Nutritional counseling and nutritional supplements: a cornerstone of multidisciplinary cancer care for cachectic patients","volume":"7","author":"Isenring","year":"2013","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.bbmt.2015.07.003_bib97","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/bmt.2011.118","article-title":"Metabolic syndrome and cardiovascular risk in survivors after hematopoietic cell transplantation","volume":"47","author":"Baker","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib98","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood-2006-05-022335","article-title":"Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study","volume":"109","author":"Baker","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.07.003_bib99","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/bmt.2008.263","article-title":"High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation","volume":"43","author":"Majhail","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.003_bib100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1053\/j.seminhematol.2011.10.001","article-title":"Cardiovascular complications in long-term survivors after allogeneic hematopoietic stem cell transplantation","volume":"49","author":"Rovo","year":"2012","journal-title":"Semin Hematol"},{"key":"10.1016\/j.bbmt.2015.07.003_bib101","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3324\/haematol.12949","article-title":"Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation","volume":"93","author":"Tichelli","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2015.07.003_bib102","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1182\/blood-2006-10-054080","article-title":"Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation","volume":"110","author":"Tichelli","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.07.003_bib103","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4158\/EP10027.RA","article-title":"Diabetes mellitus after hematopoietic stem cell transplantation","volume":"16","author":"Griffith","year":"2010","journal-title":"Endocr Pract"},{"key":"10.1016\/j.bbmt.2015.07.003_bib104","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11892-015-0581-x","article-title":"Hyperglycemia in patients with hematologic malignancies","volume":"15","author":"Healy","year":"2015","journal-title":"Curr Diab Rep"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879115004590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879115004590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:52:42Z","timestamp":1761058362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879115004590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":104,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1083879115004590"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2015.07.003","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic Nutritional Support in Allogeneic Hematopoietic Stem Cell Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2015.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}